ヤヌスキナーゼ(JAK)阻害剤の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3817)
◆英語タイトル:Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3817
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:99
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、ヤヌスキナーゼ(JAK)阻害剤の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(ルキソリチニブ、トファシチニブ、オクラシチニブ、バリシチニブ、ペフィシチニブ)、用途別市場規模(自己免疫疾患、腫瘍)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・ヤヌスキナーゼ(JAK)阻害剤の市場動向
・企業の競争状況、市場シェア
・ヤヌスキナーゼ(JAK)阻害剤の種類別市場規模(ルキソリチニブ、トファシチニブ、オクラシチニブ、バリシチニブ、ペフィシチニブ)
・ヤヌスキナーゼ(JAK)阻害剤の用途別市場規模(自己免疫疾患、腫瘍)
・ヤヌスキナーゼ(JAK)阻害剤の北米市場規模2016-2027(アメリカ、カナダ)
・ヤヌスキナーゼ(JAK)阻害剤の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・ヤヌスキナーゼ(JAK)阻害剤のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・ヤヌスキナーゼ(JAK)阻害剤の中南米市場規模2016-2027(メキシコ、ブラジル)
・ヤヌスキナーゼ(JAK)阻害剤の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Astellas Pharma, Inc.、Eli Lilly and Co.、Incyte Corp.、Novartis AG、Pfizer Inc.)
・結論
【レポートの概要】

JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy in the treatment of various chronic diseases.
The high unmet need for the treatment of graft-versus-host disease (GVHD) has also encouraged market vendors to develop novel drugs for GVHD. The lack of approved therapies for the treatment of rare cancer indications will also boost the demand for JAK inhibitors.

Market Analysis and Insights: Global Janus Kinase (JAK) Inhibitors Market
The global Janus Kinase (JAK) Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Janus Kinase (JAK) Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Janus Kinase (JAK) Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Janus Kinase (JAK) Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Janus Kinase (JAK) Inhibitors market.

Global Janus Kinase (JAK) Inhibitors Scope and Market Size
Janus Kinase (JAK) Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Janus Kinase (JAK) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Ruxolitinib
Tofacitinib
Oclacitinib
Baricitinib
Peficitinib

Segment by Application
Autoimmune Disorders
Oncology

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Astellas Pharma, Inc.
Eli Lilly and Co.
Incyte Corp.
Novartis AG
Pfizer Inc.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Janus Kinase (JAK) Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ruxolitinib
1.2.3 Tofacitinib
1.2.4 Oclacitinib
1.2.5 Baricitinib
1.2.6 Peficitinib
1.3 Market by Application
1.3.1 Global Janus Kinase (JAK) Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Autoimmune Disorders
1.3.3 Oncology
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Janus Kinase (JAK) Inhibitors Market Perspective (2016-2027)
2.2 Janus Kinase (JAK) Inhibitors Growth Trends by Regions
2.2.1 Janus Kinase (JAK) Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Janus Kinase (JAK) Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 Janus Kinase (JAK) Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 Janus Kinase (JAK) Inhibitors Industry Dynamic
2.3.1 Janus Kinase (JAK) Inhibitors Market Trends
2.3.2 Janus Kinase (JAK) Inhibitors Market Drivers
2.3.3 Janus Kinase (JAK) Inhibitors Market Challenges
2.3.4 Janus Kinase (JAK) Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Janus Kinase (JAK) Inhibitors Players by Revenue
3.1.1 Global Top Janus Kinase (JAK) Inhibitors Players by Revenue (2016-2021)
3.1.2 Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global Janus Kinase (JAK) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Janus Kinase (JAK) Inhibitors Revenue
3.4 Global Janus Kinase (JAK) Inhibitors Market Concentration Ratio
3.4.1 Global Janus Kinase (JAK) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Janus Kinase (JAK) Inhibitors Revenue in 2020
3.5 Janus Kinase (JAK) Inhibitors Key Players Head office and Area Served
3.6 Key Players Janus Kinase (JAK) Inhibitors Product Solution and Service
3.7 Date of Enter into Janus Kinase (JAK) Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Janus Kinase (JAK) Inhibitors Breakdown Data by Type
4.1 Global Janus Kinase (JAK) Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Type (2022-2027)

5 Janus Kinase (JAK) Inhibitors Breakdown Data by Application
5.1 Global Janus Kinase (JAK) Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Janus Kinase (JAK) Inhibitors Market Size (2016-2027)
6.2 North America Janus Kinase (JAK) Inhibitors Market Size by Type
6.2.1 North America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021)
6.2.2 North America Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027)
6.2.3 North America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027)
6.3 North America Janus Kinase (JAK) Inhibitors Market Size by Application
6.3.1 North America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021)
6.3.2 North America Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027)
6.3.3 North America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027)
6.4 North America Janus Kinase (JAK) Inhibitors Market Size by Country
6.4.1 North America Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021)
6.4.2 North America Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Janus Kinase (JAK) Inhibitors Market Size (2016-2027)
7.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Type
7.2.1 Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027)
7.3 Europe Janus Kinase (JAK) Inhibitors Market Size by Application
7.3.1 Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027)
7.4 Europe Janus Kinase (JAK) Inhibitors Market Size by Country
7.4.1 Europe Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type
8.2.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application
8.3.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region
8.4.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Janus Kinase (JAK) Inhibitors Market Size (2016-2027)
9.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type
9.2.1 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027)
9.3 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application
9.3.1 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027)
9.4 Latin America Janus Kinase (JAK) Inhibitors Market Size by Country
9.4.1 Latin America Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type
10.2.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application
10.3.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country
10.4.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Astellas Pharma, Inc.
11.1.1 Astellas Pharma, Inc. Company Details
11.1.2 Astellas Pharma, Inc. Business Overview
11.1.3 Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Introduction
11.1.4 Astellas Pharma, Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021)
11.1.5 Astellas Pharma, Inc. Recent Development
11.2 Eli Lilly and Co.
11.2.1 Eli Lilly and Co. Company Details
11.2.2 Eli Lilly and Co. Business Overview
11.2.3 Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Introduction
11.2.4 Eli Lilly and Co. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021)
11.2.5 Eli Lilly and Co. Recent Development
11.3 Incyte Corp.
11.3.1 Incyte Corp. Company Details
11.3.2 Incyte Corp. Business Overview
11.3.3 Incyte Corp. Janus Kinase (JAK) Inhibitors Introduction
11.3.4 Incyte Corp. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021)
11.3.5 Incyte Corp. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Janus Kinase (JAK) Inhibitors Introduction
11.4.4 Novartis AG Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Janus Kinase (JAK) Inhibitors Introduction
11.5.4 Pfizer Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021)
11.5.5 Pfizer Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヤヌスキナーゼ(JAK)阻害剤の世界市場規模・現状・予測2021年-2027年(Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。